Google Inc (NASDAQ:GOOGL) recently reached a settlement to end the shareholder lawsuits, that accused the company of selling drugs from rouge non-U.S. based pharmacies. As part of the deal, Google Inc (NASDAQ:GOOGL) will create $250 million internal program to prevent such pharmacies from advertising and selling drugs. Re/code, elaborated on the settlement in one of its posts.
Google Inc (NASDAQ:GOOGL) will be spending $50 million each year for the next five years on its internal efforts under this settlement. Google Inc (NASDAQ:GOOGL) has also agreed to pay $9.9 million in fees and expense to plaintiff attorneys. Documents filed by Google Inc (NASDAQ:GOOGL) in an Oakland federal court also revealed that the company has promised to make content about prescription drug abuse more visible and work with legitimate pharmacies to counter marketing by rogue sellers.
Disclosure: None
Suggested Article:
Most Expensive Medical Schools
